Study Stopped
Study was not producing meaningful data.
Comparison of the Efficacy of Topical Ibuprofen to Oral Ibuprofen in Adolescent Athletes
1 other identifier
interventional
60
1 country
1
Brief Summary
This study was made to compare the efficacy of topical ibuprofen in gel form with oral ibuprofen in the treatment of sub-acute soft tissue injuries while comparing the tolerability of the delivery methods
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2006
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2006
CompletedFirst Submitted
Initial submission to the registry
December 3, 2007
CompletedFirst Posted
Study publicly available on registry
December 5, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2009
CompletedJanuary 14, 2015
January 1, 2012
2.9 years
December 3, 2007
January 13, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Efficacy of Topical Ibuprofen to Oral Ibuprofen measured by numeric pain rating, swelling at injury site, and change in sports activity.
10 days to 8 weeks after initial injury or flare up
Secondary Outcomes (1)
Compare the tolerability of the two delivery methods measured by side effects.
2 weeks after starting topical and oral ibuprofen
Study Arms (2)
1
OTHERActive ibuprofen liposomal transdermal gel with placebo ibuprofen capsule
2
OTHERPlacebo ibuprofen liposomal transdermal gel with active ibuprofen capsules
Interventions
Apply by rubbing into skin for 30 to 60 seconds placebo ibuprofen 10% gel, 0.5cc to skin over injured area 3 times a day and taking active capsules of ibuprofen 3 times a day 10-40mg/kg per day, not to exceed 1200mg per day for 2 weeks.
Eligibility Criteria
You may qualify if:
- Age 12-19yo
- soft tissue injury or flare up of soft tissue injury within 10 days to 8 weeks
You may not qualify if:
- Known hypersensitivity to aspirin or any NSAID,
- allergy to eggs or egg products
- history of asthma, renal disease, GI disease, active or suspected bleeding peptic ulcer (past or present), anemia, hypertension, other systemic disease significantly affecting liver or renal function
- serious injury within six months
- currently on anticoagulants
- pregnant or lactating females
- active arthritis in affected limb
- open wounds, infected skin or fractures
- opioid use within 7 days
- severe psychological disorder
- prior topical medication applied to the painful region/area of study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sports Medicine Department at Akron Children's Hospital
Akron, Ohio, 44308, United States
Related Publications (1)
Whitefield M, O'Kane CJ, Anderson S. Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: a randomized, double-blind study. J Clin Pharm Ther. 2002 Dec;27(6):409-17. doi: 10.1046/j.1365-2710.2002.00439.x.
PMID: 12472980BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emmanuel O Adekunle, M.D.
Akron Children's Hospital
- STUDY DIRECTOR
Joseph Congeni, M.D.
Akron Children's Hospital
- PRINCIPAL INVESTIGATOR
Cynthia Bennett, MSN, CNP
Akron Children's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
December 3, 2007
First Posted
December 5, 2007
Study Start
May 1, 2006
Primary Completion
April 1, 2009
Study Completion
April 1, 2009
Last Updated
January 14, 2015
Record last verified: 2012-01